SCHEMBL5239231

SCHEMBL5239231

C=C[C@H](OC(C)=O)Oc1cccc(C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.47
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
PPARG P37231 1/20 0.43
FOLH1 Q04609 1/20 0.43
NR4A2 P43354 4/20 0.42
KMO O15229 1/20 0.41
NR1H4 Q96RI1 2/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NR4A1 P22736 1/20 0.39
NR4A3 Q92570 1/20 0.39
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39
MITF O75030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1419286 0.85 MTNR1A (0.41) KMT2ALMNAGAAPPARGPOLB
SCHEMBL4651256 0.79 AKR1C3 (0.50) AKR1C3KMT2ALMNAGAAPPARG
SCHEMBL258461 0.73 LMNA (0.68) AKR1C3KMT2ALMNAGAANR4A2
SCHEMBL29492631 0.73 LMNA (0.68) AKR1C3KMT2ALMNAGAANR4A2
SCHEMBL2878702 0.73 AKR1C3 (0.61) AKR1C3KMT2AFOLH1NR4A2KMO
SCHEMBL592781 0.73 RXRA (0.68) AKR1C3KMT2ALMNAGAAFOLH1
SCHEMBL30184304 0.73 RXRA (0.68) AKR1C3KMT2ALMNAGAAFOLH1
SCHEMBL28263720 0.72 CES2 (0.54) AKR1C3KMT2ANPC1RAB9AMITF
SCHEMBL2931454 0.72 AKR1C3 (0.56) AKR1C3KMT2ALMNAGAAFOLH1
SCHEMBL299826 0.72 ELANE (0.42) KMT2ALMNAGAAPPARGCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851208-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS Novartis AG (CH) 2007-11-07 EP disclosed
WO-2006074950-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2006-07-20 WO disclosed